Log In
BCIQ
Print this Print this
 

Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)

BCIQ
Print ChartPrint this
5 - Cancer 3 - Cancer 1 - Cancer 8 - Cancer 3 - Cancer 1 - Renal 1 - Ophthalmic 17 - Cancer 4 - Cancer 11 - Cancer 2 - Ophthalmic 10 - Cancer 1 - Cancer
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Cancer

1

10

11

4

17

3

8

1

3

5

Ophthalmic

-

2

-

-

1

-

-

-

-

-

Renal

-

-

-

-

1

-

-

-

-

-




 Products Targeting Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

25

$19,131.3M

$15,406.3M

$3,695.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today